DK464278A - Imidazolderivater og salte deraf samt fremgangsmaade og mellemprodukter til deres fremstilling - Google Patents

Imidazolderivater og salte deraf samt fremgangsmaade og mellemprodukter til deres fremstilling

Info

Publication number
DK464278A
DK464278A DK464278A DK464278A DK464278A DK 464278 A DK464278 A DK 464278A DK 464278 A DK464278 A DK 464278A DK 464278 A DK464278 A DK 464278A DK 464278 A DK464278 A DK 464278A
Authority
DK
Denmark
Prior art keywords
procedures
salts
intermediate products
imidazole derivatives
imidazole
Prior art date
Application number
DK464278A
Other languages
Danish (da)
English (en)
Inventor
P B Thorogood
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK464278A publication Critical patent/DK464278A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/201,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/093Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/16Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84Sulfur atoms
DK464278A 1977-10-19 1978-10-18 Imidazolderivater og salte deraf samt fremgangsmaade og mellemprodukter til deres fremstilling DK464278A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB4353277 1977-10-19
GB4351277 1977-10-19
GB398478 1978-02-01

Publications (1)

Publication Number Publication Date
DK464278A true DK464278A (da) 1979-04-20

Family

ID=27254350

Family Applications (1)

Application Number Title Priority Date Filing Date
DK464278A DK464278A (da) 1977-10-19 1978-10-18 Imidazolderivater og salte deraf samt fremgangsmaade og mellemprodukter til deres fremstilling

Country Status (12)

Country Link
JP (1) JPS5488268A (de)
AT (1) AT370095B (de)
AU (1) AU522055B2 (de)
CA (1) CA1111433A (de)
DE (1) DE2845406A1 (de)
DK (1) DK464278A (de)
FI (1) FI783175A (de)
IE (1) IE47749B1 (de)
IL (1) IL55858A (de)
IT (1) IT1109321B (de)
MC (1) MC1221A1 (de)
ZA (1) ZA785863B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55313A (en) * 1978-06-13 1980-01-05 Kissei Pharmaceut Co Ltd Imidazole derivative
US4430445A (en) 1979-07-19 1984-02-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel basic imidazolylmethylstyrene compound, its polymer, a process for the preparation thereof and a use as ion exchange resin
JPS6047257B2 (ja) * 1979-07-19 1985-10-21 旭化成株式会社 新規な塩基性物質およびその製造法
JPS5681566A (en) * 1979-12-05 1981-07-03 Yoshitomi Pharmaceut Ind Ltd Imidazole derivative
GR78234B (de) * 1981-03-10 1984-09-26 Ciba Geigy Ag
JPS57188570A (en) * 1981-05-14 1982-11-19 Shionogi & Co Ltd Benzylazole derivative
ZA835967B (en) * 1982-08-14 1985-04-24 Wellcome Found Imidazole derivatives and salts thereof,their synthesis,and pharmaceutical formulations
US4581370A (en) * 1983-07-12 1986-04-08 Schering A.G. Antiarrhythmic imidazoliums
JPH01316365A (ja) * 1988-03-24 1989-12-21 Shikoku Chem Corp 1−ベンジルイミダゾール化合物、該化合物の合成方法及び該化合物を用いるポリエポキシ樹脂の硬化方法

Also Published As

Publication number Publication date
MC1221A1 (fr) 1979-07-20
ATA747378A (de) 1982-07-15
AU522055B2 (en) 1982-05-13
JPS5488268A (en) 1979-07-13
IL55858A0 (en) 1979-01-31
AT370095B (de) 1983-02-25
IE782067L (en) 1979-04-19
IT7851570A0 (it) 1978-10-18
CA1111433A (en) 1981-10-27
FI783175A (fi) 1979-04-20
JPS6233227B2 (de) 1987-07-20
IL55858A (en) 1982-09-30
IT1109321B (it) 1985-12-16
AU4082478A (en) 1980-04-24
IE47749B1 (en) 1984-06-13
ZA785863B (en) 1980-05-28
DE2845406A1 (de) 1979-05-03

Similar Documents

Publication Publication Date Title
DK41479A (da) Imidazolderivater og salte deraf samt fremgangsmaade og mellemprodukter til deres fremstilling
DK42678A (da) Imidazol- og triazolderivater samt fremgangsmaade til fremstilling deraf
DK282880A (da) Aminoalkylbenzen-derivater samt fremgangsmaade til fremstilling deraf
DK20979A (da) 4-amino-5-alkylsulfonyl-0-anisamid-derivater samt fremgangsmaade til fremstilling deraf
DK47476A (da) Benzoylureido-diphenylethere samt fremgangsmade til deres fremstilling og anvendelse
FI783170A (fi) Imidazolinderivat
DK42778A (da) Imidazol- og friazolderivater samt fremgangsmaade til fremstilling deraf
DK47376A (da) Benzoylureido-nitro-diphenylethere samt fremgangsmade til deres fremstilling og anvendelse
DK291180A (da) Indolizinderivater samt fremgangsmaade til fremstilling deraf
DK477578A (da) Imidazolinderivater og salte deraf samt deres fremstilling og anvendelse
DK37278A (da) Meta-sulfonamido-benzamid-derivater samt fremgangsmaade til fremstilling deraf
DK212778A (da) Sesquiterpen-derivater og salte deraf samt fremgangsmaade til deres fremstilling
DK203378A (da) Azolylether-derivater fremgangsmaade til deres fremstilling samt deres anvendelse som fungicider
DK324078A (da) N-carloxyalkan-aminoalkan-polyhosphonsyrer og alkalimetalsalte deraf samt fremgangsmaade til fremstilling deraf
DK147378A (da) Imidazodiazepinderivater samt fremgangsmaade til fremstilling deraf
DK348278A (da) Imidazolinylbenzoesyrer,-estere og salte deraf med herbicid virkning samt deres fremstilling og anvendelse
DK388178A (da) Fluorsubstituerede phenoxybenzyloxycarbonylderivater fremgangsmaader til fremstilling deraf samt disses anvendelse som insekticider og akaricider
DK203178A (da) Thiobenzimidazolderivater deres fremstilling og anvendelse samt mellemprodukter ved fremstillingen og fremstilling af saadanne mellemprodukter
SE7811492L (sv) Kinazolinderivat, forfarande for framstellning derav samt antihyperintensiva lekemedel, innehallande dessa derivat
DK464278A (da) Imidazolderivater og salte deraf samt fremgangsmaade og mellemprodukter til deres fremstilling
DK49077A (da) Piperazinderivater samt fremgangsmade til fremstilling deraf
DK545077A (da) Thiooximcephalosporin- og penicillinderivater samt fremgangsmaader til fremstilling deraf
DK507376A (da) Heterocycliske forbindelser og fysiologisk acceptable salte deraf samt fremgangsmade til fremstilling deraf
NL7808011A (nl) Norbornaan- en norborneen-derivaten.
DK303178A (da) Benzylpyrimidiner samt fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment